BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10997697)

  • 1. Role of angiotensin II in diabetic nephropathy.
    Leehey DJ; Singh AK; Alavi N; Singh R
    Kidney Int Suppl; 2000 Sep; 77():S93-8. PubMed ID: 10997697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation.
    Singh R; Alavi N; Singh AK; Leehey DJ
    Diabetes; 1999 Oct; 48(10):2066-73. PubMed ID: 10512375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of a local renin angiotensin system in podocytes by glucose.
    Durvasula RV; Shankland SJ
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy.
    Heilig CW; Deb DK; Abdul A; Riaz H; James LR; Salameh J; Nahman NS
    Am J Nephrol; 2013; 38(1):39-49. PubMed ID: 23817135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system.
    Ko SH; Hong OK; Kim JW; Ahn YB; Song KH; Cha BY; Son HY; Kim MJ; Jeong IK; Yoon KH
    J Cell Biochem; 2006 May; 98(2):343-55. PubMed ID: 16408293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms.
    Wolf G; Ziyadeh FN
    Am J Kidney Dis; 1997 Jan; 29(1):153-63. PubMed ID: 9002545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells.
    Gruden G; Thomas S; Burt D; Zhou W; Chusney G; Gnudi L; Viberti G
    J Am Soc Nephrol; 1999 Apr; 10(4):730-7. PubMed ID: 10203356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway.
    Wolf G
    Kidney Int; 2006 Dec; 70(11):1914-9. PubMed ID: 16985515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of renal renin-angiotensin system in upstream stimulatory factor 2 transgenic mice.
    Shi L; Nikolic D; Liu S; Lu H; Wang S
    Am J Physiol Renal Physiol; 2009 Feb; 296(2):F257-65. PubMed ID: 19004931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.
    Kagami S; Border WA; Miller DE; Noble NA
    J Clin Invest; 1994 Jun; 93(6):2431-7. PubMed ID: 8200978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia.
    Weigert C; Brodbeck K; Klopfer K; Häring HU; Schleicher ED
    Diabetologia; 2002 Jun; 45(6):890-8. PubMed ID: 12107734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms.
    Wolf G
    Nephrologie; 1998; 19(7):451-6. PubMed ID: 9857383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells.
    Park SH; Han HJ
    Am J Physiol Renal Physiol; 2002 Feb; 282(2):F228-37. PubMed ID: 11788436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Link between angiotensin II and TGF-beta in the kidney.
    Wolf G
    Miner Electrolyte Metab; 1998; 24(2-3):174-80. PubMed ID: 9525702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells.
    Anderson PW; Zhang XY; Tian J; Correale JD; Xi XP; Yang D; Graf K; Law RE; Hsueh WA
    Kidney Int; 1996 Sep; 50(3):745-53. PubMed ID: 8872947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of high glucose concentration on angiotensin II- or transforming growth factor-beta-induced DNA synthesis, hypertrophy and collagen synthesis in cultured rat mesangial cells.
    Choi KH; Kang SW; Lee HY; Han DS
    Yonsei Med J; 1996 Oct; 37(5):302-11. PubMed ID: 8997162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.